Form 8-K - Current report:
SEC Accession No. 0001641172-25-019924
Filing Date
2025-07-16
Accepted
2025-07-16 17:25:27
Documents
13
Period of Report
2025-07-10
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38514
  Complete submission text file 0001641172-25-019924.txt   251321

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocea-20250710.xsd EX-101.SCH 3850
3 XBRL DEFINITION FILE ocea-20250710_def.xml EX-101.DEF 26724
4 XBRL LABEL FILE ocea-20250710_lab.xml EX-101.LAB 36896
5 XBRL PRESENTATION FILE ocea-20250710_pre.xml EX-101.PRE 25348
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6031
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 251128158
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)